{"entity":{"type":"insider","cik":"0001680329","url":"/insider/0001680329","json_url":"/insider/0001680329.json","name":"Reeve Emma","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":56,"n_filings":22,"first":"2019-11-07","last":"2026-01-06","span_basis":"filed_date"},"name_variants":[{"name":"Reeve Emma","source":"filing","n_filings":22,"first_seen":"2019-11-07","last_seen":"2026-01-06"}],"transactions":[{"id":5987781,"accession":"0001680329-26-000002","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001680329-26-000002","line_url":"/filing/0001680329-26-000002#line-3","is_derivative":false,"issuer_cik":"0001070081","issuer_name":"PTC THERAPEUTICS, INC.","issuer_ticker":"PTCT","issuer_name_source":null,"issuer_url":"/issuer/0001070081","owner_cik":"0001680329","owner_name":"Reeve Emma","owner_url":"/insider/0001680329","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":734.0,"shares_display":"734","price_per_share":76.0,"price_display":"76.00","price_state":"stated","total_value":55784.0,"total_display":"55,784.00","shares_owned_after":10666.0,"shares_owned_after_display":"10,666","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-05","filed_date":"2026-01-06","scope":"insider"},{"id":4636655,"accession":"0001680329-25-000014","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001680329-25-000014","line_url":"/filing/0001680329-25-000014#line-2","is_derivative":false,"issuer_cik":"0001070081","issuer_name":"PTC THERAPEUTICS, INC.","issuer_ticker":"PTCT","issuer_name_source":null,"issuer_url":"/issuer/0001070081","owner_cik":"0001680329","owner_name":"Reeve Emma","owner_url":"/insider/0001680329","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":733.0,"shares_display":"733","price_per_share":78.62,"price_display":"78.62","price_state":"stated","total_value":57628.46,"total_display":"57,628.46","shares_owned_after":6666.0,"shares_owned_after_display":"6,666","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-12-03","filed_date":"2025-12-05","scope":"insider"},{"id":4052813,"accession":"0001680329-25-000012","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001680329-25-000012","line_url":"/filing/0001680329-25-000012#line-2","is_derivative":false,"issuer_cik":"0001070081","issuer_name":"PTC THERAPEUTICS, INC.","issuer_ticker":"PTCT","issuer_name_source":null,"issuer_url":"/issuer/0001070081","owner_cik":"0001680329","owner_name":"Reeve Emma","owner_url":"/insider/0001680329","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":79.5,"price_display":"79.50","price_state":"stated","total_value":795000.0,"total_display":"795,000.00","shares_owned_after":6666.0,"shares_owned_after_display":"6,666","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-11-21","filed_date":"2025-11-25","scope":"insider"},{"id":4097436,"accession":"0001680329-25-000010","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001680329-25-000010","line_url":"/filing/0001680329-25-000010#line-2","is_derivative":false,"issuer_cik":"0001070081","issuer_name":"PTC THERAPEUTICS, INC.","issuer_ticker":"PTCT","issuer_name_source":null,"issuer_url":"/issuer/0001070081","owner_cik":"0001680329","owner_name":"Reeve Emma","owner_url":"/insider/0001680329","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7333.0,"shares_display":"7,333","price_per_share":74.5,"price_display":"74.50","price_state":"stated","total_value":546308.5,"total_display":"546,308.50","shares_owned_after":6666.0,"shares_owned_after_display":"6,666","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-11-12","filed_date":"2025-11-14","scope":"insider"},{"id":4438205,"accession":"0001680329-25-000008","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001680329-25-000008","line_url":"/filing/0001680329-25-000008#line-3","is_derivative":false,"issuer_cik":"0001070081","issuer_name":"PTC THERAPEUTICS, INC.","issuer_ticker":"PTCT","issuer_name_source":null,"issuer_url":"/issuer/0001070081","owner_cik":"0001680329","owner_name":"Reeve Emma","owner_url":"/insider/0001680329","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12000.0,"shares_display":"12,000","price_per_share":69.5,"price_display":"69.50","price_state":"stated","total_value":834000.0,"total_display":"834,000.00","shares_owned_after":6666.0,"shares_owned_after_display":"6,666","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-10-30","filed_date":"2025-10-31","scope":"insider"},{"id":4438200,"accession":"0001680329-25-000008","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001680329-25-000008","line_url":"/filing/0001680329-25-000008#line-2","is_derivative":false,"issuer_cik":"0001070081","issuer_name":"PTC THERAPEUTICS, INC.","issuer_ticker":"PTCT","issuer_name_source":null,"issuer_url":"/issuer/0001070081","owner_cik":"0001680329","owner_name":"Reeve Emma","owner_url":"/insider/0001680329","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3666.0,"shares_display":"3,666","price_per_share":69.5,"price_display":"69.50","price_state":"stated","total_value":254787.0,"total_display":"254,787.00","shares_owned_after":6666.0,"shares_owned_after_display":"6,666","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-10-30","filed_date":"2025-10-31","scope":"insider"},{"id":4962204,"accession":"0001680329-25-000006","txn_seq":12,"anchor":"line-12","filing_url":"/filing/0001680329-25-000006","line_url":"/filing/0001680329-25-000006#line-12","is_derivative":false,"issuer_cik":"0001070081","issuer_name":"PTC THERAPEUTICS, INC.","issuer_ticker":"PTCT","issuer_name_source":null,"issuer_url":"/issuer/0001070081","owner_cik":"0001680329","owner_name":"Reeve Emma","owner_url":"/insider/0001680329","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4591.0,"shares_display":"4,591","price_per_share":66.09,"price_display":"66.09","price_state":"stated","total_value":303419.19,"total_display":"303,419.19","shares_owned_after":12713.0,"shares_owned_after_display":"12,713","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-10-03","filed_date":"2025-10-07","scope":"insider"},{"id":4962200,"accession":"0001680329-25-000006","txn_seq":11,"anchor":"line-11","filing_url":"/filing/0001680329-25-000006","line_url":"/filing/0001680329-25-000006#line-11","is_derivative":false,"issuer_cik":"0001070081","issuer_name":"PTC THERAPEUTICS, INC.","issuer_ticker":"PTCT","issuer_name_source":null,"issuer_url":"/issuer/0001070081","owner_cik":"0001680329","owner_name":"Reeve Emma","owner_url":"/insider/0001680329","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4037.0,"shares_display":"4,037","price_per_share":66.1,"price_display":"66.10","price_state":"stated","total_value":266845.7,"total_display":"266,845.70","shares_owned_after":12216.0,"shares_owned_after_display":"12,216","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-10-03","filed_date":"2025-10-07","scope":"insider"},{"id":4962196,"accession":"0001680329-25-000006","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001680329-25-000006","line_url":"/filing/0001680329-25-000006#line-10","is_derivative":false,"issuer_cik":"0001070081","issuer_name":"PTC THERAPEUTICS, INC.","issuer_ticker":"PTCT","issuer_name_source":null,"issuer_url":"/issuer/0001070081","owner_cik":"0001680329","owner_name":"Reeve Emma","owner_url":"/insider/0001680329","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3149.0,"shares_display":"3,149","price_per_share":66.11,"price_display":"66.11","price_state":"stated","total_value":208180.39,"total_display":"208,180.39","shares_owned_after":11932.0,"shares_owned_after_display":"11,932","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-10-03","filed_date":"2025-10-07","scope":"insider"},{"id":4962189,"accession":"0001680329-25-000006","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001680329-25-000006","line_url":"/filing/0001680329-25-000006#line-9","is_derivative":false,"issuer_cik":"0001070081","issuer_name":"PTC THERAPEUTICS, INC.","issuer_ticker":"PTCT","issuer_name_source":null,"issuer_url":"/issuer/0001070081","owner_cik":"0001680329","owner_name":"Reeve Emma","owner_url":"/insider/0001680329","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3028.0,"shares_display":"3,028","price_per_share":65.09,"price_display":"65.09","price_state":"stated","total_value":197092.52,"total_display":"197,092.52","shares_owned_after":17304.0,"shares_owned_after_display":"17,304","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-10-03","filed_date":"2025-10-07","scope":"insider"},{"id":4962184,"accession":"0001680329-25-000006","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001680329-25-000006","line_url":"/filing/0001680329-25-000006#line-8","is_derivative":false,"issuer_cik":"0001070081","issuer_name":"PTC THERAPEUTICS, INC.","issuer_ticker":"PTCT","issuer_name_source":null,"issuer_url":"/issuer/0001070081","owner_cik":"0001680329","owner_name":"Reeve Emma","owner_url":"/insider/0001680329","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2729.0,"shares_display":"2,729","price_per_share":65.05,"price_display":"65.05","price_state":"stated","total_value":177521.45,"total_display":"177,521.45","shares_owned_after":16253.0,"shares_owned_after_display":"16,253","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-10-03","filed_date":"2025-10-07","scope":"insider"},{"id":4962180,"accession":"0001680329-25-000006","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001680329-25-000006","line_url":"/filing/0001680329-25-000006#line-7","is_derivative":false,"issuer_cik":"0001070081","issuer_name":"PTC THERAPEUTICS, INC.","issuer_ticker":"PTCT","issuer_name_source":null,"issuer_url":"/issuer/0001070081","owner_cik":"0001680329","owner_name":"Reeve Emma","owner_url":"/insider/0001680329","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2381.0,"shares_display":"2,381","price_per_share":66.87,"price_display":"66.87","price_state":"stated","total_value":159217.47,"total_display":"159,217.47","shares_owned_after":10332.0,"shares_owned_after_display":"10,332","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-10-03","filed_date":"2025-10-07","scope":"insider"},{"id":4962169,"accession":"0001680329-25-000006","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001680329-25-000006","line_url":"/filing/0001680329-25-000006#line-6","is_derivative":false,"issuer_cik":"0001070081","issuer_name":"PTC THERAPEUTICS, INC.","issuer_ticker":"PTCT","issuer_name_source":null,"issuer_url":"/issuer/0001070081","owner_cik":"0001680329","owner_name":"Reeve Emma","owner_url":"/insider/0001680329","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2163.0,"shares_display":"2,163","price_per_share":65.02,"price_display":"65.02","price_state":"stated","total_value":140638.26,"total_display":"140,638.26","shares_owned_after":15081.0,"shares_owned_after_display":"15,081","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-10-03","filed_date":"2025-10-07","scope":"insider"},{"id":4962164,"accession":"0001680329-25-000006","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001680329-25-000006","line_url":"/filing/0001680329-25-000006#line-5","is_derivative":false,"issuer_cik":"0001070081","issuer_name":"PTC THERAPEUTICS, INC.","issuer_ticker":"PTCT","issuer_name_source":null,"issuer_url":"/issuer/0001070081","owner_cik":"0001680329","owner_name":"Reeve Emma","owner_url":"/insider/0001680329","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1884.0,"shares_display":"1,884","price_per_share":66.89,"price_display":"66.89","price_state":"stated","total_value":126020.76,"total_display":"126,020.76","shares_owned_after":10332.0,"shares_owned_after_display":"10,332","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-10-03","filed_date":"2025-10-07","scope":"insider"},{"id":4962161,"accession":"0001680329-25-000006","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001680329-25-000006","line_url":"/filing/0001680329-25-000006#line-4","is_derivative":false,"issuer_cik":"0001070081","issuer_name":"PTC THERAPEUTICS, INC.","issuer_ticker":"PTCT","issuer_name_source":null,"issuer_url":"/issuer/0001070081","owner_cik":"0001680329","owner_name":"Reeve Emma","owner_url":"/insider/0001680329","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1600.0,"shares_display":"1,600","price_per_share":66.93,"price_display":"66.93","price_state":"stated","total_value":107088.0,"total_display":"107,088.00","shares_owned_after":10332.0,"shares_owned_after_display":"10,332","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-10-03","filed_date":"2025-10-07","scope":"insider"},{"id":5176076,"accession":"0001680329-25-000004","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001680329-25-000004","line_url":"/filing/0001680329-25-000004#line-6","is_derivative":false,"issuer_cik":"0001070081","issuer_name":"PTC THERAPEUTICS, INC.","issuer_ticker":"PTCT","issuer_name_source":null,"issuer_url":"/issuer/0001070081","owner_cik":"0001680329","owner_name":"Reeve Emma","owner_url":"/insider/0001680329","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":59.5,"price_display":"59.50","price_state":"stated","total_value":595000.0,"total_display":"595,000.00","shares_owned_after":10332.0,"shares_owned_after_display":"10,332","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-09-11","filed_date":"2025-09-16","scope":"insider"},{"id":5176073,"accession":"0001680329-25-000004","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001680329-25-000004","line_url":"/filing/0001680329-25-000004#line-5","is_derivative":false,"issuer_cik":"0001070081","issuer_name":"PTC THERAPEUTICS, INC.","issuer_ticker":"PTCT","issuer_name_source":null,"issuer_url":"/issuer/0001070081","owner_cik":"0001680329","owner_name":"Reeve Emma","owner_url":"/insider/0001680329","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3534.0,"shares_display":"3,534","price_per_share":59.5,"price_display":"59.50","price_state":"stated","total_value":210273.0,"total_display":"210,273.00","shares_owned_after":11666.0,"shares_owned_after_display":"11,666","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-09-11","filed_date":"2025-09-16","scope":"insider"},{"id":5176069,"accession":"0001680329-25-000004","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001680329-25-000004","line_url":"/filing/0001680329-25-000004#line-4","is_derivative":false,"issuer_cik":"0001070081","issuer_name":"PTC THERAPEUTICS, INC.","issuer_ticker":"PTCT","issuer_name_source":null,"issuer_url":"/issuer/0001070081","owner_cik":"0001680329","owner_name":"Reeve Emma","owner_url":"/insider/0001680329","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1334.0,"shares_display":"1,334","price_per_share":59.5,"price_display":"59.50","price_state":"stated","total_value":79373.0,"total_display":"79,373.00","shares_owned_after":10332.0,"shares_owned_after_display":"10,332","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-09-11","filed_date":"2025-09-16","scope":"insider"},{"id":5176066,"accession":"0001680329-25-000004","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001680329-25-000004","line_url":"/filing/0001680329-25-000004#line-3","is_derivative":false,"issuer_cik":"0001070081","issuer_name":"PTC THERAPEUTICS, INC.","issuer_ticker":"PTCT","issuer_name_source":null,"issuer_url":"/issuer/0001070081","owner_cik":"0001680329","owner_name":"Reeve Emma","owner_url":"/insider/0001680329","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":837.0,"shares_display":"837","price_per_share":59.5,"price_display":"59.50","price_state":"stated","total_value":49801.5,"total_display":"49,801.50","shares_owned_after":10332.0,"shares_owned_after_display":"10,332","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-09-11","filed_date":"2025-09-16","scope":"insider"},{"id":8087310,"accession":"0001415889-23-008704","txn_seq":12,"anchor":"line-12","filing_url":"/filing/0001415889-23-008704","line_url":"/filing/0001415889-23-008704#line-12","is_derivative":false,"issuer_cik":"0001070081","issuer_name":"PTC THERAPEUTICS, INC.","issuer_ticker":"PTCT","issuer_name_source":null,"issuer_url":"/issuer/0001070081","owner_cik":"0001680329","owner_name":"Reeve Emma","owner_url":"/insider/0001680329","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1402.0,"shares_display":"1,402","price_per_share":59.5378,"price_display":"59.54","price_state":"stated","total_value":83471.9956,"total_display":"83,472.00","shares_owned_after":7200.0,"shares_owned_after_display":"7,200","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-05-23","filed_date":"2023-05-24","scope":"insider"},{"id":8087308,"accession":"0001415889-23-008704","txn_seq":11,"anchor":"line-11","filing_url":"/filing/0001415889-23-008704","line_url":"/filing/0001415889-23-008704#line-11","is_derivative":false,"issuer_cik":"0001070081","issuer_name":"PTC THERAPEUTICS, INC.","issuer_ticker":"PTCT","issuer_name_source":null,"issuer_url":"/issuer/0001070081","owner_cik":"0001680329","owner_name":"Reeve Emma","owner_url":"/insider/0001680329","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1093.0,"shares_display":"1,093","price_per_share":59.532,"price_display":"59.53","price_state":"stated","total_value":65068.476,"total_display":"65,068.48","shares_owned_after":7200.0,"shares_owned_after_display":"7,200","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-05-23","filed_date":"2023-05-24","scope":"insider"},{"id":8087307,"accession":"0001415889-23-008704","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001415889-23-008704","line_url":"/filing/0001415889-23-008704#line-10","is_derivative":false,"issuer_cik":"0001070081","issuer_name":"PTC THERAPEUTICS, INC.","issuer_ticker":"PTCT","issuer_name_source":null,"issuer_url":"/issuer/0001070081","owner_cik":"0001680329","owner_name":"Reeve Emma","owner_url":"/insider/0001680329","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":157.0,"shares_display":"157","price_per_share":59.5171,"price_display":"59.52","price_state":"stated","total_value":9344.1847,"total_display":"9,344.18","shares_owned_after":7200.0,"shares_owned_after_display":"7,200","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-05-23","filed_date":"2023-05-24","scope":"insider"},{"id":8087301,"accession":"0001415889-23-008704","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001415889-23-008704","line_url":"/filing/0001415889-23-008704#line-6","is_derivative":false,"issuer_cik":"0001070081","issuer_name":"PTC THERAPEUTICS, INC.","issuer_ticker":"PTCT","issuer_name_source":null,"issuer_url":"/issuer/0001070081","owner_cik":"0001680329","owner_name":"Reeve Emma","owner_url":"/insider/0001680329","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3948.0,"shares_display":"3,948","price_per_share":59.5313,"price_display":"59.53","price_state":"stated","total_value":235029.5724,"total_display":"235,029.57","shares_owned_after":7200.0,"shares_owned_after_display":"7,200","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-05-22","filed_date":"2023-05-24","scope":"insider"},{"id":8087299,"accession":"0001415889-23-008704","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001415889-23-008704","line_url":"/filing/0001415889-23-008704#line-5","is_derivative":false,"issuer_cik":"0001070081","issuer_name":"PTC THERAPEUTICS, INC.","issuer_ticker":"PTCT","issuer_name_source":null,"issuer_url":"/issuer/0001070081","owner_cik":"0001680329","owner_name":"Reeve Emma","owner_url":"/insider/0001680329","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2995.0,"shares_display":"2,995","price_per_share":59.5335,"price_display":"59.53","price_state":"stated","total_value":178302.8325,"total_display":"178,302.83","shares_owned_after":7200.0,"shares_owned_after_display":"7,200","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-05-22","filed_date":"2023-05-24","scope":"insider"},{"id":8087297,"accession":"0001415889-23-008704","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001415889-23-008704","line_url":"/filing/0001415889-23-008704#line-4","is_derivative":false,"issuer_cik":"0001070081","issuer_name":"PTC THERAPEUTICS, INC.","issuer_ticker":"PTCT","issuer_name_source":null,"issuer_url":"/issuer/0001070081","owner_cik":"0001680329","owner_name":"Reeve Emma","owner_url":"/insider/0001680329","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":173.0,"shares_display":"173","price_per_share":59.5242,"price_display":"59.52","price_state":"stated","total_value":10297.6866,"total_display":"10,297.69","shares_owned_after":7200.0,"shares_owned_after_display":"7,200","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-05-22","filed_date":"2023-05-24","scope":"insider"},{"id":7826200,"accession":"0001415889-23-006831","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-23-006831","line_url":"/filing/0001415889-23-006831#line-2","is_derivative":false,"issuer_cik":"0001070081","issuer_name":"PTC THERAPEUTICS, INC.","issuer_ticker":"PTCT","issuer_name_source":null,"issuer_url":"/issuer/0001070081","owner_cik":"0001680329","owner_name":"Reeve Emma","owner_url":"/insider/0001680329","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4228.0,"shares_display":"4,228","price_per_share":55.0381,"price_display":"55.04","price_state":"stated","total_value":232701.0868,"total_display":"232,701.09","shares_owned_after":7300.0,"shares_owned_after_display":"7,300","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-04-21","filed_date":"2023-04-25","scope":"insider"},{"id":7826192,"accession":"0001415889-23-006831","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-23-006831","line_url":"/filing/0001415889-23-006831#line-1","is_derivative":false,"issuer_cik":"0001070081","issuer_name":"PTC THERAPEUTICS, INC.","issuer_ticker":"PTCT","issuer_name_source":null,"issuer_url":"/issuer/0001070081","owner_cik":"0001680329","owner_name":"Reeve Emma","owner_url":"/insider/0001680329","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":55.57,"price_display":"55.57","price_state":"stated","total_value":5557.0,"total_display":"5,557.00","shares_owned_after":7200.0,"shares_owned_after_display":"7,200","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-04-21","filed_date":"2023-04-25","scope":"insider"},{"id":4145287,"accession":"0001562180-21-001509","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001562180-21-001509","line_url":"/filing/0001562180-21-001509#line-4","is_derivative":false,"issuer_cik":"0001434418","issuer_name":"CONSTELLATION PHARMACEUTICALS INC","issuer_ticker":"CNST","issuer_name_source":null,"issuer_url":"/issuer/0001434418","owner_cik":"0001680329","owner_name":"Reeve Emma","owner_url":"/insider/0001680329","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6260.0,"shares_display":"6,260","price_per_share":37.5996,"price_display":"37.60","price_state":"stated","total_value":235373.496,"total_display":"235,373.50","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-22","filed_date":"2021-02-23","scope":"insider"},{"id":4145282,"accession":"0001562180-21-001509","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001562180-21-001509","line_url":"/filing/0001562180-21-001509#line-2","is_derivative":false,"issuer_cik":"0001434418","issuer_name":"CONSTELLATION PHARMACEUTICALS INC","issuer_ticker":"CNST","issuer_name_source":null,"issuer_url":"/issuer/0001434418","owner_cik":"0001680329","owner_name":"Reeve Emma","owner_url":"/insider/0001680329","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4010.0,"shares_display":"4,010","price_per_share":37.7102,"price_display":"37.71","price_state":"stated","total_value":151217.902,"total_display":"151,217.90","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-19","filed_date":"2021-02-23","scope":"insider"},{"id":5376063,"accession":"0001562180-21-001319","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001562180-21-001319","line_url":"/filing/0001562180-21-001319#line-4","is_derivative":false,"issuer_cik":"0001434418","issuer_name":"CONSTELLATION PHARMACEUTICALS INC","issuer_ticker":"CNST","issuer_name_source":null,"issuer_url":"/issuer/0001434418","owner_cik":"0001680329","owner_name":"Reeve Emma","owner_url":"/insider/0001680329","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1100.0,"shares_display":"1,100","price_per_share":37.5846,"price_display":"37.58","price_state":"stated","total_value":41343.06,"total_display":"41,343.06","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-18","filed_date":"2021-02-19","scope":"insider"},{"id":5376060,"accession":"0001562180-21-001319","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001562180-21-001319","line_url":"/filing/0001562180-21-001319#line-2","is_derivative":false,"issuer_cik":"0001434418","issuer_name":"CONSTELLATION PHARMACEUTICALS INC","issuer_ticker":"CNST","issuer_name_source":null,"issuer_url":"/issuer/0001434418","owner_cik":"0001680329","owner_name":"Reeve Emma","owner_url":"/insider/0001680329","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":410.0,"shares_display":"410","price_per_share":37.5557,"price_display":"37.56","price_state":"stated","total_value":15397.837,"total_display":"15,397.84","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-17","filed_date":"2021-02-19","scope":"insider"},{"id":2202513,"accession":"0001562180-20-007432","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001562180-20-007432","line_url":"/filing/0001562180-20-007432#line-3","is_derivative":false,"issuer_cik":"0001434418","issuer_name":"CONSTELLATION PHARMACEUTICALS INC","issuer_ticker":"CNST","issuer_name_source":null,"issuer_url":"/issuer/0001434418","owner_cik":"0001680329","owner_name":"Reeve Emma","owner_url":"/insider/0001680329","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5720.0,"shares_display":"5,720","price_per_share":35.1058,"price_display":"35.11","price_state":"stated","total_value":200805.176,"total_display":"200,805.18","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-21","filed_date":"2020-12-22","scope":"insider"},{"id":2623795,"accession":"0001179110-20-011991","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001179110-20-011991","line_url":"/filing/0001179110-20-011991#line-4","is_derivative":false,"issuer_cik":"0001070081","issuer_name":"PTC THERAPEUTICS, INC.","issuer_ticker":"PTCT","issuer_name_source":null,"issuer_url":"/issuer/0001070081","owner_cik":"0001680329","owner_name":"Reeve Emma","owner_url":"/insider/0001680329","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000.0,"shares_display":"1,000","price_per_share":68.0,"price_display":"68.00","price_state":"stated","total_value":68000.0,"total_display":"68,000.00","shares_owned_after":1650.0,"shares_owned_after_display":"1,650","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-14","filed_date":"2020-12-16","scope":"insider"},{"id":2623787,"accession":"0001179110-20-011991","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001179110-20-011991","line_url":"/filing/0001179110-20-011991#line-3","is_derivative":false,"issuer_cik":"0001070081","issuer_name":"PTC THERAPEUTICS, INC.","issuer_ticker":"PTCT","issuer_name_source":null,"issuer_url":"/issuer/0001070081","owner_cik":"0001680329","owner_name":"Reeve Emma","owner_url":"/insider/0001680329","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":972.0,"shares_display":"972","price_per_share":68.0,"price_display":"68.00","price_state":"stated","total_value":66096.0,"total_display":"66,096.00","shares_owned_after":1650.0,"shares_owned_after_display":"1,650","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-14","filed_date":"2020-12-16","scope":"insider"},{"id":2946917,"accession":"0001562180-20-004418","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001562180-20-004418","line_url":"/filing/0001562180-20-004418#line-4","is_derivative":false,"issuer_cik":"0001434418","issuer_name":"CONSTELLATION PHARMACEUTICALS INC","issuer_ticker":"CNST","issuer_name_source":null,"issuer_url":"/issuer/0001434418","owner_cik":"0001680329","owner_name":"Reeve Emma","owner_url":"/insider/0001680329","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":233.0,"shares_display":"233","price_per_share":38.3539,"price_display":"38.35","price_state":"stated","total_value":8936.4587,"total_display":"8,936.46","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-08","filed_date":"2020-06-10","scope":"insider"},{"id":2946912,"accession":"0001562180-20-004418","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001562180-20-004418","line_url":"/filing/0001562180-20-004418#line-3","is_derivative":false,"issuer_cik":"0001434418","issuer_name":"CONSTELLATION PHARMACEUTICALS INC","issuer_ticker":"CNST","issuer_name_source":null,"issuer_url":"/issuer/0001434418","owner_cik":"0001680329","owner_name":"Reeve Emma","owner_url":"/insider/0001680329","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":212.0,"shares_display":"212","price_per_share":36.5907,"price_display":"36.59","price_state":"stated","total_value":7757.2284,"total_display":"7,757.23","shares_owned_after":377.0,"shares_owned_after_display":"377","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-08","filed_date":"2020-06-10","scope":"insider"},{"id":2946905,"accession":"0001562180-20-004418","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001562180-20-004418","line_url":"/filing/0001562180-20-004418#line-2","is_derivative":false,"issuer_cik":"0001434418","issuer_name":"CONSTELLATION PHARMACEUTICALS INC","issuer_ticker":"CNST","issuer_name_source":null,"issuer_url":"/issuer/0001434418","owner_cik":"0001680329","owner_name":"Reeve Emma","owner_url":"/insider/0001680329","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":144.0,"shares_display":"144","price_per_share":37.6658,"price_display":"37.67","price_state":"stated","total_value":5423.8752,"total_display":"5,423.88","shares_owned_after":233.0,"shares_owned_after_display":"233","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-08","filed_date":"2020-06-10","scope":"insider"},{"id":3189943,"accession":"0001562180-20-003563","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001562180-20-003563","line_url":"/filing/0001562180-20-003563#line-8","is_derivative":false,"issuer_cik":"0001434418","issuer_name":"CONSTELLATION PHARMACEUTICALS INC","issuer_ticker":"CNST","issuer_name_source":null,"issuer_url":"/issuer/0001434418","owner_cik":"0001680329","owner_name":"Reeve Emma","owner_url":"/insider/0001680329","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16062.0,"shares_display":"16,062","price_per_share":49.5345,"price_display":"49.53","price_state":"stated","total_value":795623.139,"total_display":"795,623.14","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-05-11","filed_date":"2020-05-12","scope":"insider"},{"id":3189916,"accession":"0001562180-20-003563","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001562180-20-003563","line_url":"/filing/0001562180-20-003563#line-3","is_derivative":false,"issuer_cik":"0001434418","issuer_name":"CONSTELLATION PHARMACEUTICALS INC","issuer_ticker":"CNST","issuer_name_source":null,"issuer_url":"/issuer/0001434418","owner_cik":"0001680329","owner_name":"Reeve Emma","owner_url":"/insider/0001680329","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12741.0,"shares_display":"12,741","price_per_share":49.5295,"price_display":"49.53","price_state":"stated","total_value":631055.3595,"total_display":"631,055.36","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-05-08","filed_date":"2020-05-12","scope":"insider"},{"id":3149971,"accession":"0001562180-20-003063","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001562180-20-003063","line_url":"/filing/0001562180-20-003063#line-2","is_derivative":false,"issuer_cik":"0001434418","issuer_name":"CONSTELLATION PHARMACEUTICALS INC","issuer_ticker":"CNST","issuer_name_source":null,"issuer_url":"/issuer/0001434418","owner_cik":"0001680329","owner_name":"Reeve Emma","owner_url":"/insider/0001680329","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":760.0,"shares_display":"760","price_per_share":35.289,"price_display":"35.29","price_state":"stated","total_value":26819.64,"total_display":"26,819.64","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-04-17","filed_date":"2020-04-20","scope":"insider"},{"id":2918977,"accession":"0001562180-20-003027","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001562180-20-003027","line_url":"/filing/0001562180-20-003027#line-2","is_derivative":false,"issuer_cik":"0001434418","issuer_name":"CONSTELLATION PHARMACEUTICALS INC","issuer_ticker":"CNST","issuer_name_source":null,"issuer_url":"/issuer/0001434418","owner_cik":"0001680329","owner_name":"Reeve Emma","owner_url":"/insider/0001680329","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1225.0,"shares_display":"1,225","price_per_share":35.2022,"price_display":"35.20","price_state":"stated","total_value":43122.695,"total_display":"43,122.70","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-04-14","filed_date":"2020-04-16","scope":"insider"},{"id":3149963,"accession":"0001562180-20-002990","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001562180-20-002990","line_url":"/filing/0001562180-20-002990#line-4","is_derivative":false,"issuer_cik":"0001434418","issuer_name":"CONSTELLATION PHARMACEUTICALS INC","issuer_ticker":"CNST","issuer_name_source":null,"issuer_url":"/issuer/0001434418","owner_cik":"0001680329","owner_name":"Reeve Emma","owner_url":"/insider/0001680329","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":589.0,"shares_display":"589","price_per_share":35.0179,"price_display":"35.02","price_state":"stated","total_value":20625.5431,"total_display":"20,625.54","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-04-09","filed_date":"2020-04-13","scope":"insider"},{"id":3149961,"accession":"0001562180-20-002990","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001562180-20-002990","line_url":"/filing/0001562180-20-002990#line-3","is_derivative":false,"issuer_cik":"0001434418","issuer_name":"CONSTELLATION PHARMACEUTICALS INC","issuer_ticker":"CNST","issuer_name_source":null,"issuer_url":"/issuer/0001434418","owner_cik":"0001680329","owner_name":"Reeve Emma","owner_url":"/insider/0001680329","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":111.0,"shares_display":"111","price_per_share":35.0179,"price_display":"35.02","price_state":"stated","total_value":3886.9869,"total_display":"3,886.99","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-04-09","filed_date":"2020-04-13","scope":"insider"},{"id":2760246,"accession":"0001562180-20-001251","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001562180-20-001251","line_url":"/filing/0001562180-20-001251#line-4","is_derivative":false,"issuer_cik":"0001434418","issuer_name":"CONSTELLATION PHARMACEUTICALS INC","issuer_ticker":"CNST","issuer_name_source":null,"issuer_url":"/issuer/0001434418","owner_cik":"0001680329","owner_name":"Reeve Emma","owner_url":"/insider/0001680329","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5521.0,"shares_display":"5,521","price_per_share":35.0551,"price_display":"35.06","price_state":"stated","total_value":193539.2071,"total_display":"193,539.21","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-02-13","filed_date":"2020-02-14","scope":"insider"},{"id":2760237,"accession":"0001562180-20-001251","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001562180-20-001251","line_url":"/filing/0001562180-20-001251#line-2","is_derivative":false,"issuer_cik":"0001434418","issuer_name":"CONSTELLATION PHARMACEUTICALS INC","issuer_ticker":"CNST","issuer_name_source":null,"issuer_url":"/issuer/0001434418","owner_cik":"0001680329","owner_name":"Reeve Emma","owner_url":"/insider/0001680329","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1103.0,"shares_display":"1,103","price_per_share":35.0172,"price_display":"35.02","price_state":"stated","total_value":38623.9716,"total_display":"38,623.97","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-02-12","filed_date":"2020-02-14","scope":"insider"},{"id":2580228,"accession":"0001562180-20-001123","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001562180-20-001123","line_url":"/filing/0001562180-20-001123#line-6","is_derivative":false,"issuer_cik":"0001434418","issuer_name":"CONSTELLATION PHARMACEUTICALS INC","issuer_ticker":"CNST","issuer_name_source":null,"issuer_url":"/issuer/0001434418","owner_cik":"0001680329","owner_name":"Reeve Emma","owner_url":"/insider/0001680329","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7212.0,"shares_display":"7,212","price_per_share":35.04,"price_display":"35.04","price_state":"stated","total_value":252708.48,"total_display":"252,708.48","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-02-11","filed_date":"2020-02-12","scope":"insider"},{"id":2580225,"accession":"0001562180-20-001123","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001562180-20-001123","line_url":"/filing/0001562180-20-001123#line-5","is_derivative":false,"issuer_cik":"0001434418","issuer_name":"CONSTELLATION PHARMACEUTICALS INC","issuer_ticker":"CNST","issuer_name_source":null,"issuer_url":"/issuer/0001434418","owner_cik":"0001680329","owner_name":"Reeve Emma","owner_url":"/insider/0001680329","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1430.0,"shares_display":"1,430","price_per_share":35.04,"price_display":"35.04","price_state":"stated","total_value":50107.2,"total_display":"50,107.20","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-02-11","filed_date":"2020-02-12","scope":"insider"},{"id":2580215,"accession":"0001562180-20-001123","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001562180-20-001123","line_url":"/filing/0001562180-20-001123#line-2","is_derivative":false,"issuer_cik":"0001434418","issuer_name":"CONSTELLATION PHARMACEUTICALS INC","issuer_ticker":"CNST","issuer_name_source":null,"issuer_url":"/issuer/0001434418","owner_cik":"0001680329","owner_name":"Reeve Emma","owner_url":"/insider/0001680329","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200.0,"shares_display":"200","price_per_share":35.0,"price_display":"35.00","price_state":"stated","total_value":7000.0,"total_display":"7,000.00","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-02-10","filed_date":"2020-02-12","scope":"insider"},{"id":8229003,"accession":"0001562180-19-005413","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001562180-19-005413","line_url":"/filing/0001562180-19-005413#line-9","is_derivative":false,"issuer_cik":"0001434418","issuer_name":"CONSTELLATION PHARMACEUTICALS INC","issuer_ticker":"CNST","issuer_name_source":null,"issuer_url":"/issuer/0001434418","owner_cik":"0001680329","owner_name":"Reeve Emma","owner_url":"/insider/0001680329","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":24264.0,"shares_display":"24,264","price_per_share":18.4025,"price_display":"18.40","price_state":"stated","total_value":446518.26,"total_display":"446,518.26","shares_owned_after":34630.0,"shares_owned_after_display":"34,630","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-11-06","filed_date":"2019-11-08","scope":"insider"},{"id":8228999,"accession":"0001562180-19-005413","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001562180-19-005413","line_url":"/filing/0001562180-19-005413#line-8","is_derivative":false,"issuer_cik":"0001434418","issuer_name":"CONSTELLATION PHARMACEUTICALS INC","issuer_ticker":"CNST","issuer_name_source":null,"issuer_url":"/issuer/0001434418","owner_cik":"0001680329","owner_name":"Reeve Emma","owner_url":"/insider/0001680329","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15740.0,"shares_display":"15,740","price_per_share":29.7497,"price_display":"29.75","price_state":"stated","total_value":468260.278,"total_display":"468,260.28","shares_owned_after":726.0,"shares_owned_after_display":"726","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-11-06","filed_date":"2019-11-08","scope":"insider"}],"next_cursor":"2019-11-06|8228999","ledger_fault":false,"count":{"value":56,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":56,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":56},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001070081","name":"PTC THERAPEUTICS, INC.","url":"/issuer/0001070081","role":"Director","n_filings":10,"first_seen":"2020-12-16","last_seen":"2026-01-06"},{"type":"issuer","type_label":"ISSUER","cik":"0001434418","name":"CONSTELLATION PHARMACEUTICALS INC","url":"/issuer/0001434418","role":"Officer (Chief Financial Officer)","n_filings":12,"first_seen":"2019-11-07","last_seen":"2021-02-23"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001680329","retrieved_at":"2026-08-22T01:43:19+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}